Table 2 Cox model analysis for the association between the HHLA2 expression level and patients’ clinical parameters
Variables | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Gender (male: female) | 0.923 (0.448–1.901) | 0.828 | 1.415 (0.637–3.145) | 0.394 |
Age (> 60: ≤ 60 years) | 2.971 (1.397–6.320) | 0.005 | 3.504 (1.578–7.784) | 0.002 |
Tumor size (> 7: ≤ 7 cm) | 2.757 (1.347–5.643) | 0.005 | 1.098 (0.444–2.715) | 0.840 |
TNM stage (II + III + IV: I) | 3.762 (1.836–7.705) | 0.000 | 3.745 (1.514–9.260) | 0.007 |
HHLA2 expression (high: low) | 3.179 (1.565–6.456) | 0.001 | 3.128 (1.510–6.487) | 0.002 |